title: Effect of estrogen receptors (reports from the FDA, NIH, ACOG, and NAMS) and the role of testosterone and bone density.
authors.affiliation: US Food and Drug Administration, DHHS, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Davis
authors.forename: Trent
authors.initials: T
authors.lastname: MacKay
authors.forename: Wulf
authors.initials: W
authors.lastname: Utian
authors.forename: Steven
authors.initials: S
authors.lastname: Grinspoon
mesh_terms: D015519:Bone Density / Q000187:drug effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism*; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D009316:National Institutes of Health (U.S.); D010024:Osteoporosis / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011960:Receptors, Estrogen / Q000378:metabolism*; D012955:Societies, Medical; D013739:Testosterone / Q000378:metabolism*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D011960:Receptors, Estrogen; D013739:Testosterone